Higher hospital costs for pediatric congenital heart disease surgery were associated with a 13.6% reduction in risk-adjusted inpatient mortality from the 25th to 75th cost percentile (p=0.002).
Cohort (n=35,446)
Yes
Does treatment in higher cost hospitals reduce risk-adjusted inpatient mortality in children undergoing surgery for congenital heart disease?
Greater hospital costs are associated with lower risk-adjusted inpatient mortality for children undergoing congenital heart disease surgery.
Effect estimate: 13.6% reduction
p-value: p=.002
OBJECTIVE: To determine the association between hospital costs and risk-adjusted inpatient mortality among children undergoing surgery for congenital heart disease (CHD) in U.S. acute-care hospitals. DATA SOURCES/STUDY SETTINGS: Retrospective cohort study of 35,446 children in 2003, 2006, and 2009 Kids' Inpatient Database (KID). STUDY DESIGN: Cross-sectional logistic regression of risk-adjusted inpatient mortality and hospital costs, adjusting for a variety of patient-, hospital-, and community-level confounders. DATA COLLECTION/EXTRACTION METHODS: We identified relevant discharges in the KID using the AHRQ Pediatric Quality Indicator for pediatric heart surgery mortality, and linked these records to hospital characteristics from American Hospital Association Surveys and community characteristics from the Census. PRINCIPAL FINDINGS: Children undergoing CHD surgery in higher cost hospitals had lower risk-adjusted inpatient mortality (p=.002). An increase from the 25th percentile of treatment costs to the 75th percentile was associated with a 13.6 percent reduction in risk-adjusted mortality. CONCLUSIONS: Greater hospital costs are associated with lower risk-adjusted inpatient mortality for children undergoing CHD surgery. The specific mechanisms by which greater costs improve mortality merit further exploration.
Romley et al. (Mon,) conducted a cohort in Congenital heart disease (n=35,446). Higher hospital costs vs. Lower hospital costs was evaluated on Risk-adjusted inpatient mortality (13.6% reduction, p=.002). Higher hospital costs for pediatric congenital heart disease surgery were associated with a 13.6% reduction in risk-adjusted inpatient mortality from the 25th to 75th cost percentile (p=0.002).